Abstract:A quinoxaline scaffold exhibits various bioactivities in pharmacotherapeutic interests. In this research, twelve quinoxaline derivatives were synthesized and evaluated as new acetylcholinesterase inhibitors. We found all compounds showed potent inhibitory activity against acetylcholinesterase (AChE) with IC50 values of 0.077 to 50.080 μM, along with promising predicted drug-likeness and blood–brain barrier (BBB) permeation. In addition, potent butyrylcholinesterase (BChE) inhibitory activity with IC50 values of 14.91 to 60.95 μM was observed in some compounds. Enzyme kinetic study revealed the most potent compound (6c) as a mixed-type AChE inhibitor. No cytotoxicity from the quinoxaline derivatives was noticed in the human neuroblastoma cell line (SHSY5Y). In silico study suggested the compounds preferred the peripheral anionic site (PAS) to the catalytic anionic site (CAS), which was different from AChE inhibitors (tacrine and galanthamine). We had proposed the molecular design guided for quinoxaline derivatives targeting the PAS site. Therefore, the quinoxaline derivatives could offer the lead for the newly developed candidate as potential acetylcholinesterase inhibitors.

Synthesis and Evaluation of Novel Xanthone Derivatives As Potent Ache Inhibitors

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

Design, Synthesis and Evaluation of Flavonoid Derivatives As Potent AChE Inhibitors.

Design, Synthesis and Evaluation of Galanthamine Derivatives As Acetylcholinesterase Inhibitors

Synthesis And In Vitro Evaluation Of 1,3,4-Thiadiazol-2-Yl Urea Derivatives As Novel Ache Inhibitors

Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors.

Design, Synthesis and Pharmacological Evaluation of Chalcone Derivatives As Acetylcholinesterase Inhibitors

Synthesis and Biological Evaluation of Helicid Analogues As Novel Acetylcholinesterase Inhibitors

2-(2-Indolyl-)-4(3h)-quinazolines Derivates As New Inhibitors of AChE: Design, Synthesis, Biological Evaluation and Molecular Modelling

Design, Synthesis and Evaluation of Difunctionalized 4-Hydroxybenzaldehyde Derivatives As Novel Cholinesterase Inhibitors

Design, Synthesis and Molecular Modeling of Isothiochromanone Derivatives As Acetylcholinesterase Inhibitors

Design, Synthesis and Biological Evaluation of Pyrano[2,3-b]-naphthoquinone Derivatives as Acetylcholinesterase Inhibitors

Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors.

Synthesis, biological evaluation, and molecular docking studies of xanthone sulfonamides as ACAT inhibitors.

Design, Synthesis and Preliminary Structure-Activity Relationship Investigation of Nitrogen-Containing Chalcone Derivatives As Acetylcholinesterase and Butyrylcholinesterase Inhibitors: a Further Study Based on Flavokawain B Mannich Base Derivatives.

Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.

Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold

Design, synthesis and biological evaluation of novel quinoline [4,3-b] chromene derivatives as AChE inhibitors through an efficient one-pot, four-component microwave-mediated reaction

Discovery of quinazolin-4(3 H )-one derivatives as novel AChE inhibitors with anti-inflammatory activities

Design, Synthesis, And Acetylcholinesterase Inhibition Assay Of Novel 9-(1-(Substituted-Benzyl) Piperidin-4-Yl)-2-Chloro-9h-Purin-6-Amine Derivatives

2-Phenoxy-indan-1-one Derivatives As Acetylcholinesterase Inhibitors: A Study on the Importance of Modifications at the Side Chain on the Activity